"Nel cuore della città di San Donato Milanese, l’IRCCS Policlinico San Donato è una realtà di ricerca clinica e universitaria. Oggi, tra le più rinomate strutture di eccellenza cardiochirurgica nel panorama italiano, il Policlinico rappresenta il centro di riferimento per i ricoveri di emergenza all’interno dell’unità cardiovascolare, conquistando il primo posto come struttura ad aver realizzato il maggior numero di interventi di chirurgia cardiaca in Italia (più di 1500 per anno)."

During the past decade, IRCCS Policlinico San Donato conducted 132 clinical trials. In the 10-year time frame, 132 clinical trials started and 24 clinical trials were completed, i.e. on average, 18.2% percent of trials that started reached the finish line to date. In the past 5 years, 52 clinical trials started and 22 clinical trials were completed. i.e. 42.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "IRCCS Policlinico San Donato" #1 sponsor was "IRCCS Policlinico S. Donato" with 30 trials, followed by "Abbott Medical Devices" with 14 trials sponsored, "Ospedale San Donato" with 8 trials sponsored, "Hoffmann-La Roche" with 5 trials sponsored and "University of Milan" with 5 trials sponsored. Other sponsors include 96 different institutions and companies that sponsored additional 77 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "IRCCS Policlinico San Donato" #1 collaborator was "IRCCS Policlinico S. Donato" with 4 trials as a collaborator, "University of Pavia" with 4 trials as a collaborator, "Abbott" with 2 trials as a collaborator, "Centro Cardiologico Monzino" with 2 trials as a collaborator and "Istituto Di Ricerche Farmacologiche Mario Negri" with 2 trials as a collaborator. Other collaborators include 55 different institutions and companies that were collaborators in the rest 62 trials.

According to Clinical.Site data, the most researched conditions in "IRCCS Policlinico San Donato" are "Ulcerative Colitis" (10 trials), "Aortic Valve Stenosis" (9 trials), "Coronary Artery Disease" (9 trials), "Crohn Disease" (7 trials) and "Mitral Regurgitation" (6 trials). Many other conditions were trialed in "IRCCS Policlinico San Donato" in a lesser frequency.

Most popular intervention types in "IRCCS Policlinico San Donato" are "Device" (65 trials), "Drug" (51 trials), "Procedure" (20 trials), "Diagnostic Test" (11 trials) and "Other" (9 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (21 trials), "Etrolizumab" (4 trials), "Etrasimod" (3 trials), "GED-0301" (3 trials) and "Ustekinumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "IRCCS Policlinico San Donato" are 161 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "IRCCS Policlinico San Donato". undefined are not yet recruiting, 36 are recruiting, 22 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 73 completed trials in IRCCS Policlinico San Donato, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in IRCCS Policlinico San Donato, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 56 trials that are defined as “Not Applicable".